Ola Vedin works in Heart Failure & Transplant affiliated with AstraZeneca (Sweden).
Ola Vedin serves as the Global Clinical Head for Late Clinical CVRM at AstraZeneca in Sweden. He previously held positions at Boehringer Ingelheim and worked as a specialist in cardiology at Uppsala University Hospital. His research includes studies on heart failure treatments, cardiovascular risk factors, and related metabolic conditions.
65 pubs · 3,199 cites · h-index 27
Postgraduate Course in Heart Failure
University of Zurich
2017
PhD
Uppsala University
2015
MD
Uppsala University
2005
AstraZeneca
2024 - Present
AstraZeneca
2023 - 2024
Boehringer Ingelheim
2021 - 2023
Boehringer Ingelheim
2021 - 2021
Uppsala University Hospital
2015 - 2018